Canopy Competitors
| CGC Stock | USD 1.17 0.02 1.74% |
Canopy Growth vs Takeda Pharmaceutical Correlation
Very good diversification
The correlation between Canopy Growth Corp and TAK is -0.35 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Canopy Growth Corp and TAK in the same portfolio, assuming nothing else is changed.
Moving together with Canopy Stock
Moving against Canopy Stock
| 0.47 | AMG | Amgen Inc | PairCorr |
| 0.43 | HCM | HUTCHMED China | PairCorr |
| 0.42 | H6D | Haleon PLC | PairCorr |
| 0.42 | VTYX | Ventyx Biosciences | PairCorr |
| 0.4 | CVG | CSPC Pharmaceutical | PairCorr |
Canopy Growth Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Canopy Growth and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Canopy and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Canopy Growth Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Canopy Stock performing well and Canopy Growth Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Canopy Growth's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| COR | 1.17 | 0.01 | (0.03) | 0.16 | 2.31 | 2.01 | 10.81 | |||
| REGN | 1.49 | 0.12 | 0.05 | 0.33 | 1.41 | 3.40 | 8.86 | |||
| IDXX | 1.26 | (0.19) | 0.00 | (0.07) | 0.00 | 3.61 | 10.16 | |||
| HLN | 1.03 | 0.13 | 0.03 | 0.89 | 1.44 | 2.76 | 5.40 | |||
| CI | 1.22 | 0.01 | (0.02) | 0.11 | 1.27 | 2.64 | 7.36 | |||
| ELV | 1.55 | (0.05) | 0.00 | 0.06 | 2.87 | 3.20 | 19.95 | |||
| BDX | 1.21 | 0.20 | 0.19 | 0.31 | 0.70 | 3.22 | 7.13 | |||
| ELAN | 1.59 | 0.21 | 0.14 | 0.25 | 1.53 | 3.78 | 10.56 | |||
| ARGX | 1.20 | (0.16) | 0.00 | 4.32 | 0.00 | 2.29 | 7.34 | |||
| TAK | 0.89 | 0.42 | 0.42 | 10.79 | 0.00 | 2.49 | 4.49 |
Cross Equities Net Income Analysis
Compare Canopy Growth Corp and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COR | (207.7 M) | 719 M | 433.7 M | 276.5 M | (134.9 M) | 1.4 B | 414.5 M | 1.7 B | 855.4 M | (3.4 B) | 1.5 B | 1.7 B | 1.7 B | 1.5 B | 1.6 B | 1.8 B | 1.9 B |
| REGN | (3.3 M) | (221.8 M) | 750.3 M | 424.4 M | 348.1 M | 636.1 M | 895.5 M | 1.2 B | 2.4 B | 2.1 B | 3.5 B | 8.1 B | 4.3 B | 4 B | 4.4 B | 4.5 B | 4.7 B |
| IDXX | 3.2 M | 161.8 M | 178.3 M | 187.8 M | 181.9 M | 192.1 M | 222 M | 263.1 M | 377 M | 427.7 M | 581.8 M | 744.8 M | 679.1 M | 845 M | 887.9 M | 1.1 B | 1.1 B |
| HLN | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 1.1 B | 1.4 B | 1.1 B | 1 B | 1.4 B | 1.7 B | 1.2 B |
| CI | (854.6 M) | 1.3 B | 1.6 B | 1.5 B | 2.1 B | 2.1 B | 1.9 B | 2.2 B | 2.6 B | 5.1 B | 8.5 B | 5.4 B | 6.7 B | 5.2 B | 3.4 B | 6 B | 6.3 B |
| ELV | 172.4 M | 2.6 B | 2.7 B | 2.7 B | 2.6 B | 2.6 B | 2.5 B | 3.8 B | 3.8 B | 4.8 B | 4.6 B | 6.1 B | 5.9 B | 6 B | 6 B | 5.7 B | 3.3 B |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| ELAN | (210.8 M) | (210.8 M) | (210.8 M) | (210.8 M) | (210.8 M) | (210.8 M) | (47.9 M) | (310.7 M) | 86.5 M | 67.9 M | (560.1 M) | (483 M) | (78 M) | (1.2 B) | 338 M | 304.2 M | 319.4 M |
| ARGX | (4.5 M) | (4.5 M) | (12.8 M) | (8.5 M) | (12.5 M) | (16.7 M) | (22.5 M) | (33.7 M) | (76.2 M) | (181.2 M) | (608.5 M) | (407.6 M) | (709.6 M) | (295.1 M) | 833 M | 749.7 M | 787.2 M |
| TAK | 119.6 B | 124.2 B | 131.2 B | 106.7 B | (145.8 B) | 80.2 B | 114.9 B | 186.9 B | 109.1 B | 44.2 B | 376 B | 230.1 B | 317 B | 144.1 B | 107.9 B | 97.1 B | 155.3 B |
Canopy Growth Corp and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Canopy Growth Corp financial statement analysis. It represents the amount of money remaining after all of Canopy Growth Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Canopy Growth Competitive Analysis
The better you understand Canopy Growth competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Canopy Growth's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Canopy Growth's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Canopy Growth Competition Performance Charts
Five steps to successful analysis of Canopy Growth Competition
Canopy Growth's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Canopy Growth Corp in relation to its competition. Canopy Growth's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Canopy Growth in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Canopy Growth's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Canopy Growth Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Canopy Growth position
In addition to having Canopy Growth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Apparel Thematic Idea Now
Apparel
Companies manufacturing textile accessories and apparel products. The Apparel theme has 22 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Canopy Growth Correlation with its peers. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Will Pharmaceuticals sector continue expanding? Could Canopy diversify its offerings? Factors like these will boost the valuation of Canopy Growth. Projected growth potential of Canopy fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Canopy Growth data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.36) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Canopy Growth Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Canopy Growth's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Canopy Growth's market price to deviate significantly from intrinsic value.
It's important to distinguish between Canopy Growth's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Canopy Growth should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Canopy Growth's market price signifies the transaction level at which participants voluntarily complete trades.